Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M14 |
Human metastatic melanoma cells | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene SI | publication | A. Sarma et al., The American J. of Pathology, 2021, 191, 2, doi.org/10.1016/j.ajpath.2020.10.015 | Link | ||
Ma-Mel-86a |
Malignant melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Löffek et al., Front. Oncol., 2015, 5:234; doi: 10.3389/fonc.2015.00234 | Link | ||
Ma-Mel-86a |
Malignant melanoma cell line | Human | skin | cell line | plasmid | stable transfection | Metafectene | publication | N. Ullrich et al., Cancer Res., May 2015; 75: 1897 - 1907 | Link | |||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | V. Vella et al., Cells, 2019, 8, 1017, doi:10.3390/cells8091017 | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene | publication | M. Ansems et al., Breast Cancer Res. Treat., 2015, 149:693–703; DOI: 10.1007/s10549-015-3281-y | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | B. Ljepoja et al., Scientific Reports, 2018, 8:6927, DOI:10.1038/s41598-018-25240-y | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene EASY | publication | K. Haagenson, Dissertation, 2013, Wayne State University | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | S. E. Semina et al., Cancer Investigation, 2017, DOI: 10.1080/07357907.2017.1368081 | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene EASY | publication | K. K. Haagenson et al., Oncotarget, 2014, 5 (4) : 1101-1110 | Link | |
MCF7 |
Human breast fibrocystic disease cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene | publication | Y. Radestock et al., Ann. N.Y. Acad Sci. 1041:462-469 (2005). Doi: 10.1196/annals.1282.070 | ||
MDA-MB-435S |
Human breast cancer metastatic melanoma cell line | ATCC HTB-129 | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | |
MDA-MB-436 |
Human breast cancer cell line | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene EASY | publication | J. N. Apfel, Dissertation, 2014, Julius-Maximilians-Universitaet Wuerzburg | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | S. C. Klinger et al., The FEBS Journal, 2016, 283:2476-2493; doi:10.1111/febs.13758 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | B. Singh et al., Journal of Cell Science, 2015, 128: 3444-3455; doi:10.1242/jcs.170852 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | M. Norman et al., J. Cell Sci., Jan 2012; 125: 59 - 66 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | M. Brunati et al., eLife, 2015,4:e08887; DOI: 10.7554/eLife.08887 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | F. J. Arjona et al., European J. of Physiology, 2019, 471: 845–860, doi.org/10.1007/s00424-018-2234-9 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | E. P. M. van Loon et al., Am. J. Physiol. Renal Physiol., 2015, 309: F359-F368; doi:10.1152/ajprenal.00240.2014 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | W. Neuhofer et al., Frontiers in Physiol., 5 , article 123, doi: 10.3389/fphys.2014.00123 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | application note | ![]() |
||
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | F. J. Arjona et al., Europ. J. of Physiol. , 2018, doi.org/10.1007/s00424-018-2234-9 | Link | |
MDCK II |
Madin darby canine kidney cell line | ATCC CRL-2936 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | M. Behrendt et al., J. Biol. Chem., Feb 2010; 285: 4143 - 4152 | Link | |
MDCK II |
Madin darby canine kidney cell line | ATCC CRL-2936 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | K. Kopplow et al., Mol. Pharmacol., Oct 2005; 68: 1031 - 1038 | Link |